Previous studies found that high amino acid uptake measured by alpha-[11C]-methyl-L-tryptophan (AMT)-PET can accurately detect glioblastoma cell infiltration both in enhancing and non-enhancing tumor portions. However, AMT-PET is not widely available for clinical use. This study explores a novel U-Net which can accurately detect high tryptophan uptake glioblastoma regions using clinical multi-modal MRI data. The resulting U-Net led to 0.85±0.08 sensitivity and 0.99±0.00 specificity to predict AMT-PET tumor regions showing significant negative correlation with survival period, suggesting that an end-to-end deep learning of multi-modal MRI data may be effective for survival prediction of glioblastoma patient without the need of AMT-PET.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords